Skip to main content
An official website of the United States government

Hyperpolarized Xenon-129 Magnetic Resonance Imaging for Improving Radiation Therapy for Lung Cancer

Trial Status: active

This clinical trial studies how well hyperpolarized xenon-129 magnetic resonance imaging (MRI) works for improving radiation therapy (RT) for lung cancer. Radiation induced lung injury (RILI) remains a serious side effect of RT treatment and results in symptoms of breathlessness, exercise limitations, poor lung function and an overall reduction in patient quality of life. Recent advances using MRI with inhaled xenon (Xe) gas provide a safe, repeatable method for visualizing lung function inclusive of ventilation, inflammation, and gas exchange. This trial is being done to explore using MRI scans with xenon to better image lung function, how lung function changes after radiation therapy, and to guide radiation therapy away from parts of the lung that have good function.